126 related articles for article (PubMed ID: 31686842)
1. LncRNA ELF3-AS1 is involved in the regulation of oral squamous cell carcinoma cell proliferation by reprogramming glucose metabolism.
Chu H; Li Z; Gan Z; Yang Z; Wu Z; Rong M
Onco Targets Ther; 2019; 12():6857-6863. PubMed ID: 31686842
[TBL] [Abstract][Full Text] [Related]
2. lncRNA NR2F2-AS1 inhibits the methylation of miR-494 to regulate oral squamous cell carcinoma cell proliferation.
Liang Y; Wu X; Lee J; Yu D; Su J; Guo M; Meng N; Qin J; Fan X
Arch Oral Biol; 2022 Feb; 134():105316. PubMed ID: 34896865
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ELF3-antisense RNA 1 promotes osteosarcoma cell proliferation by upregulating Kruppel-like factor 12 potentially via methylation of the microRNA-205 gene.
Yuan J; Kang J; Yang M
Oncol Lett; 2020 Mar; 19(3):2475-2480. PubMed ID: 32194747
[TBL] [Abstract][Full Text] [Related]
4. miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Chen YH; Song Y; Yu YL; Cheng W; Tong X
Oncol Lett; 2019 Jun; 17(6):5441-5446. PubMed ID: 31186763
[TBL] [Abstract][Full Text] [Related]
5. Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2.
Li T; Liu D; Li C; Ru L; Wang X
Cancer Manag Res; 2021; 13():7897-7908. PubMed ID: 34703311
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PSMG3 Antisense RNA 1 is correlated with oral squamous cell carcinoma and regulates cancer cell proliferation by targeting premature microRNA-141.
Ouyang S; Xuan F; Zhang X; Yuan W; Fan X; Wang J
Am J Cancer Res; 2023; 13(1):227-235. PubMed ID: 36777518
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NCK1-AS1 in plasma distinguishes oral ulcer from early-stage oral squamous cell carcinoma.
Le F; Ou Y; Luo P; Zhong X
J Biol Res (Thessalon); 2020 Dec; 27():16. PubMed ID: 33194849
[TBL] [Abstract][Full Text] [Related]
8. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
[TBL] [Abstract][Full Text] [Related]
9. lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1.
Luo J; Wang H; Wang L; Wang G; Yao Y; Xie K; Li X; Xu L; Shen Y; Ren B
Mol Ther Nucleic Acids; 2021 Sep; 25():11-24. PubMed ID: 34141461
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
Li H; Jiang J
J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
Li X; Ren H
Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
Xu XJ; Yuan J; Sun WJ; Chen QY; Lin Y; Tang L; Liang LZ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7726-7734. PubMed ID: 30536316
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
Feng H; Zhang X; Lai W; Wang J
Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
[TBL] [Abstract][Full Text] [Related]
15. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1821-1828. PubMed ID: 32141551
[TBL] [Abstract][Full Text] [Related]
16. lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p.
Hou C; Wang X; Du B
Exp Ther Med; 2020 Aug; 20(2):978-984. PubMed ID: 32742341
[TBL] [Abstract][Full Text] [Related]
17. LINC01638 lncRNA promotes cancer cell proliferation in hepatocellular carcinoma by increasing cancer cell glucose uptake.
Chen X; Wang L; Wang H
Oncol Lett; 2019 Oct; 18(4):3811-3816. PubMed ID: 31516592
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer.
Yang CM; Wang TH; Chen HC; Li SC; Lee MC; Liou HH; Liu PF; Tseng YK; Shiue YL; Ger LP; Tsai KW
Clin Epigenetics; 2016; 8():129. PubMed ID: 27933111
[TBL] [Abstract][Full Text] [Related]
19. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-SNHG16 Silencing Inhibits Prostate Carcinoma Cell Growth, Downregulate GLUT1 Expression and Reduce Glucose Uptake.
Shao M; Yu Z; Zou J
Cancer Manag Res; 2020; 12():1751-1757. PubMed ID: 32210616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
